Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli

Biotechnology Progress

Volumn 23, Issue 1, 2007, Pages 286-292

  Kang, Hui ^a   Sun, Ai You ^a   Shen, Ya Ling ^a   Wei, Dong Zhi ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

REFOLDING; SPECIFIC GROWTH RATE; TRAIL/APO2L;

FLUORESCENCE; PROTEINS; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPY; UREA;

ESCHERICHIA COLI;

RECOMBINANT PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

CELL INCLUSION; CELL PROLIFERATION; CHEMISTRY; CONFERENCE PAPER; ESCHERICHIA COLI; GENETICS; METABOLISM; METHODOLOGY; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN FOLDING; ULTRASTRUCTURE;

CELL PROLIFERATION; ESCHERICHIA COLI; INCLUSION BODIES; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN FOLDING; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

ESCHERICHIA COLI;

EID: 33847141872     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp060238c     Document Type: Conference Paper

References (40)

1. Aggarwal, B. B.; Kohr, W. J.; Hass, P. E.; Moffat, B.; Spencer, S. A.; Henzel, W. J.; Bringman, T. S.; Nedwin, G. E.; Goeddel, D. V.; Harkins, R. N. Human tumor necrosis factor. J. Biol. Chem. 1985, 260, 2345-2354.
2. Bowden, G. A.; Paredes, A. M.; Georgiou, G. Structure and morphology of protein inclusion bodies in Escherichia coli. Bio/Technology 1991, 9, 725-730.
3. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of the protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
4. Carrio, M. M.; Cubarsi, R.; Villaverde, A. Fine architecture of bacterial inclusion bodies. FEBS Lett. 2000, 471 (1), 7-11.
5. Corchero, J. L. Cubarsi, R.; Enfors, S.; Villaverde, A. Limited in vivo proteolysis of aggregated proteins. Biochem. Biophys. Res. Commun. 1997, 237, 325-330.
6. Curless, C.; Pope, J.; Tsai, L. Effect of preinduction specific growth rate on recombinant alpha consensus interferon synthesis in Escherichia coli. Biotechnol. Prog. 1990, 6, 149-152.
7. Dalbadie-McFarland, G.; Nietzel, J. J.; Richards, J. H. Active-site mutants of β-lactamase: Use of an inactive double mutant to study requirements for catalysis. Biochemistry 1986, 25, 332-338.
8. Georgiou, G.; Baneyx, F. Expression, purification and immobilization of a protein A-β-lactamase hybrid protein. Ann. N. Y. Acad. Sci. 1990, 589, 139-147.
9. Hymowiz, S. G.; O'Connell, M. P.; Ultch, M. H.; Hurst, A.; Totpal, K.; Ashkenazi, A.; Vos, A. M.; de, Kelley, R. F. A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimetric Apo2L/TRAIL. Biochemistry 2000, 39, 633-640.
10. Jevsevar, S.; Gaberc-Porekar, V.; Fonda, I.; Podobnik, B.; Grdadolnik, J.; Menart, V. Production of nonclassical inclusion bodies from which correctly folded protein can be extracted. Biotechnol. Prog. 2005, 21, 632-639.
11. Jin, H.; Uddin, M. S.; Huang, Y. L.; Teo, W. K. Purification and renaturation of recombinant human lymphotoxin (tumor necrosis factor beta) expressed in Escherichia coli as inclusion bodies. J. Chem. Tech. Biotechnol. 1994, 59, 67-72.
12. Khan, R. H.; Appa, R. K. B. C.; Eshwari, A. N. S,; Totey, S. M.; Panda, A. K. Solubilization refolding and characterization of recombinant ovine growth hormone from inclusion bodies of E. coli. Biotechnol. Prog. 1998, 14, 722-728.
13. Kiefhaber, T.; Rudoph, R.; Kohler, H. H.; Buchner, J. Protein aggregation in vivo and in vivo: A quantitative model of the kinetic competition between folding and aggregation. Bio/Technology 1991, 9, 825-829.
14. Kopetzki, E.; Schumacher, G.; Buckel, P. Control of formation of active soluble or inactive insoluble baker's yeast alpha glucosidase P1 in Escherichia coli by induction and growth temperature. Mol. Gen. Genet. 1989, 216, 149-155.
15. Lawrence, D.; Shahrokh, Z.; Marsters, S.; Achilles, K.; Shih, D.; Mounho, B.; Hillan, K.; Totpal, K.; DeForge, L.; Schow, P.; Hooley, J.; Sherwood, S.; Pai, R.; Leung, S.; Khan, L.; Gliniak, B.; Bussiere, J.; Smith, C. A.; Strom, S. S.; Kelley, S.; Fox, J. A.; Thomas, D.; Ashkenazi, A. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat. Med. 2001, 7, 383-385.
16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
17. LeBlanc, H. N.; Ashkenazi, A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 2003, 10, 66-75.
18. Luo, Q. P.; Shen, Y. L.; Wei, D. Z.; Cao, W. Optimization of culture on the overproduction of TRAIL in high-cell-density culture by recombinant Escherichia coli. Appl. Microbiol. Biotechnol. 2006, 71, 184-191.
19. Matsubara, M.; Nohara, D.; Sulakai, T. Difference between guanidinium chloride and urea as denaturants of globular protein: the possibility application to improved refolding processes. Chem. Pharm. Bull. 1992, 40 (2), 550-552.
20. Minsky, A.; Summers, R. G.; Knowles, J. R. Secretion of β-lactamase into the periplasm of Escherichia coli: Evidence for a distinct release step associated with a conformational change. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 4180-4184.
21. Nam, G. H.; Kwan, Y. C. Association of human tumor necrosis factor-related apoptosis inducing ligand with membrane upon acidification. Eur. J. Biochem. 2002, 269, 5280-5287.
22. Pitti, R. M.; Marsters, S. A.; Ruppert, S.; Donahue, C. J.; Moore, A.; Ashkenazi, A. J. Biol. Chem. 1996, 271, 12687-12690.
23. Przybycien, T. M.; Dunn, J. P.; Valax, P.; Georgiou, G. Secondary structure characterization of β-lactamase inclusion bodies. Protein Eng. 1994, 7, 131-136.
24. Riesenberg, D.; Menzel, K.; Schulz, V.; Schumann, K.; Veith, G.; Zuber, G.; Knorre, W. A. High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1. Appl. Microbiol. Biotechnol. 1990, 34, 77-82.
25. Rudolph, R. Renaturation of recombinant, disulfide-bonded proteins from "inclusion bodies". In Modern Methods in Protein and Nucleic Acid Analysis; Tschesche, H., Ed.; Walter de Gruyter: Berlin, New York, 1990; pp 149-171.
26. Shin, C. S.; Hong, M. S.; Kim, D. Y.; Shin, H. C.; Lee, J. Growth-associated synthesis of recombinant human glucagons and human growth hormone in high-cell-density cultures of Escherichia coli. Appl. Microbiol. Biotechnol. 1998, 49, 364-370.
27. Shen, Y. L.; Zhang, Y.; Sun, A. Y.; Xia, X. X.; Wei, D. Z. High-level production of soluble tumor necrosis factor-related apoptosis inducing ligand (Apo2L/TRAIL) in high-density cultivation of recombinant Escherichia coli using a combined feeding strategy. Biotechnol. Lett. 2004, 26, 981-984.
28. Shen, Y. L.; Xia, X. X.; Zhang, Y.; Liu, J. W.; Wei, D. Z. Refolding and purification of Apo2L/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. Biotechnol. Lett. 2003, 25, 2097-2101.
29. Siegel, R.; Ryu, D. D. Y. Kinetic study of instability of recombinant plasmid pPLc23trpA1 in E. coli using two stage continuous culture system. Biotechnol. Bioeng. 1985, 27, 28-33.
30. Taylor, G.; Hoare, M.; Gray, D. R.; Marston, F. A. O. Size and density of protein inclusion bodies. Bio/Technology 1986, 4, 553-557.
31. Vasina, J. A.; Baneyx, F. Expression of aggregation-prone recombinant proteins at low temperatures: a comparative study of the Escherichia coli cspA and tac promoter systems. Protein Expression Purif. 1997, 9 (2), 211-218.
32. Vecchio, P. D.; Graziano, G.; Granata, V.; Barone, G.; Marndrich, L.; Rossi, M.; Manco, G. Denaturing action of urea and guanidine hydrochloride towards two thermophilic esterases. Biochem. J. 2002, 367, 857-863.
33. Viaplana, E.; Feliu, J. X.; Corchero, J. L.; Villaverde, A. Reversible activation of a cryptic cleavage site within E. coli beta-galactosidase in beta-galactosidase fusion proteins. Biophys. Biochem. Acta 1997, 1343, 221-226.
34. Wang, L. H.; Zhu, Y. P.; Lou, Y. H.; Zhou, J. S.; Peng, Y. Z.; Qiu, Y.; Jiao, B. H. Higher density fermentation in preparation of recombinant soluble human TRAIL. Dier Junyi Daxue Xuebao 2002, 23, 132-135.
35. Weickert, M. J.; Pagratis, M.; Curry, S. R.; Blackmore, R. Stabilization of apoglobin by low temperature increases yield of soluble recombinant hemoglobin in Escherichia coli. Appl. Environ. Microbiol. 1997, 63, 4313-4320.
36. Wiley: S. R.; Schooley, K.; Smolak, P. J.; Din, W. S.; Huang, C. P.; Nicholl, J. K.; Sutherland, G. R.; Smith, T. D.; Rauch, C.; Smith, C. A.; and Goodwin, R. G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3, 673-682.
37. Worrall, D. M.; Gross, N. H. The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli. Aust. J. Biotechnol. 1989, 3, 28-32.
38. Xia, X. X.; Shen, Y. L.; Wei, D. Z. Purification and characterization of recombinant sTRAIL epressed in Escherichia coli. Acta. Biochim. Biophys. Sin. 2004, 36 (2), 118-122.
39. Yeh, S. R.; Rousseau, D. L. Folding intermediates in cytochrome C. Nature Struct. Biol. 1998, 5 (3), 222-228.
40. Yin, L.; Jian, C.; Ying, Y. M.; Shi, Y. L.; Yoon, M. K. Effect of additives and fed-batch culture strategies on the production of glutathione by recombinant Escherichia coli. Process Biochem. 1998, 33, 709-714.